Abschluss eines nicht exklusiven Rabattvertrages nach§ 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Ipratropiumbromid (ATC-Code: R03BB01) innerhalb des Zeitraumes vom 01.10.2026 bis zum 30.09.2028 mit jederzeitiger Möglichkeit des Vertragsabschlusses während der Laufzeit („open-house-Modell“).

TENDER DESCRIPTION

For the active substance ipratropium bromide (ATC code: R03BB01), AOK Niedersachsen offers non-exclusive discount contracts. For the period until the entry into force of exclusive contracts as a result of a formal procurement procedure in accordance with Part 4 of the GWB, AOK Niedersachsen offers all interested pharmaceutical companies discount contracts, without any selection decision. Contract awards take place within the framework of an “open-house model” and serve as a bridge between the start of generic competition (patent expiry) and the awarding of exclusive contracts. The contracts offered are non-exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Niedersachsen. Under the open-house model, uniform conditions apply to all participants. Contract contents, terms and conditions and access procedures are uniform—individual negotiations are generally not conducted. The contract terms are for a maximum of twenty-four months; the earliest contract start date is 01.10.2026. All contracts end no later than 30.09.2028, irrespective of the date on which the respective contract is concluded. A joining and/or contract conclusion may take…

TENDER BRIEF

TENDER DOCUMENTS